FDA.reportPublic FDA data

ETHOSUXIMIDE

Substance profile for UNII 5SEH9X1D1D, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for ETHOSUXIMIDE
Structure render from PubChem CID 3291

Substance Identity#

UNII
5SEH9X1D1D
Preferred term
ETHOSUXIMIDE
Registry number
77-67-8
EC number
201-048-7
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C7H11NO2
Chemical structure for ETHOSUXIMIDE
Structure render from PubChem CID 3291

Chemical And Database Identifiers#

SMILES
CCC1(C)CC(=O)NC1=O
RxCUI
4135
PubChem
3291
NCIt
C47523
INN ID
1077

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound3291pubchem.ncbi.nlm.nih.gov/compound/3291
RxNorm4135mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=4135
NCI ThesaurusC47523ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47523
FDA Substance Registration System5SEH9X1D1Dprecision.fda.gov/uniisearch/srs/unii/5SEH9X1D1D
European Community number201-048-7commonchemistry.cas.org/results?q=201-048-7

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTEthosuximide Capsules, USP1
ACTIVE MOIETYEthosuximide Capsules, USP1
ACTIVE INGREDIENTEthosuximide Capsules,USP1
ACTIVE MOIETYEthosuximide Capsules,USP1
ACTIVE INGREDIENTZARONTIN (ETHOSUXIMIDE) CAPSULE [PARKE-DAVIS DIV OF PFIZER INC]14
ACTIVE MOIETYZARONTIN (ETHOSUXIMIDE) CAPSULE [PARKE-DAVIS DIV OF PFIZER INC]14
ACTIVE INGREDIENTZARONTIN (ETHOSUXIMIDE) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]12
ACTIVE MOIETYZARONTIN (ETHOSUXIMIDE) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]12
ACTIVE MOIETYETHOSUXIMIDE CAPSULE [PLIVA INC.]9
ACTIVE INGREDIENTETHOSUXIMIDE CAPSULE [PLIVA INC.]9
ACTIVE INGREDIENTETHOSUXIMIDE SOLUTION [TEVA PHARMACEUTICALS USA INC]5
ACTIVE MOIETYETHOSUXIMIDE SOLUTION [TEVA PHARMACEUTICALS USA INC]5
ACTIVE MOIETYETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.]4
ACTIVE INGREDIENTETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.]4
ACTIVE MOIETYETHOSUXIMIDE CAPSULE [VERSAPHARM INCORPORATED]3
ACTIVE INGREDIENTETHOSUXIMIDE CAPSULE [VERSAPHARM INCORPORATED]3
ACTIVE MOIETYETHOSUXIMIDE SOLUTION [MIKART, INC.]3
ACTIVE INGREDIENTETHOSUXIMIDE SOLUTION [MIKART, INC.]3
ACTIVE MOIETYETHOSUXIMIDE CAPSULE [GREENSTONE LLC]2
ACTIVE INGREDIENTETHOSUXIMIDE CAPSULE [GREENSTONE LLC]2
ACTIVE INGREDIENTETHOSUXIMIDE SOLUTION [GREENSTONE LLC]2
ACTIVE MOIETYETHOSUXIMIDE SOLUTION [GREENSTONE LLC]2
ACTIVE MOIETYETHOSUXIMIDE SOLUTION [VERSAPHARM INCORPORATED]2
ACTIVE INGREDIENTETHOSUXIMIDE SOLUTION [VERSAPHARM INCORPORATED]2
ACTIVE INGREDIENTETHOSUXIMIDE CAPSULE [HERITAGE PHARMACEUTICALS INC.]1
ACTIVE MOIETYETHOSUXIMIDE CAPSULE [HERITAGE PHARMACEUTICALS INC.]1